Deok‐Hwan Yang

2.1k total citations
124 papers, 1.3k citations indexed

About

Deok‐Hwan Yang is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, Deok‐Hwan Yang has authored 124 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pathology and Forensic Medicine, 49 papers in Hematology and 44 papers in Oncology. Recurrent topics in Deok‐Hwan Yang's work include Lymphoma Diagnosis and Treatment (52 papers), Acute Myeloid Leukemia Research (18 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Deok‐Hwan Yang is often cited by papers focused on Lymphoma Diagnosis and Treatment (52 papers), Acute Myeloid Leukemia Research (18 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Deok‐Hwan Yang collaborates with scholars based in South Korea, United States and Canada. Deok‐Hwan Yang's co-authors include Je‐Jung Lee, Hyeoung‐Joon Kim, Jae‐Sook Ahn, Yeo‐Kyeoung Kim, Sung‐Hoon Jung, Jae‐Yong Kwak, Ik‐Joo Chung, Sang Kyun Sohn, Ho‐Jin Shin and Joon Ho Moon and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Deok‐Hwan Yang

115 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deok‐Hwan Yang South Korea 20 488 437 386 279 256 124 1.3k
Jae‐Sook Ahn South Korea 21 647 1.3× 454 1.0× 373 1.0× 206 0.7× 374 1.5× 132 1.4k
Esa Jantunen Finland 27 839 1.7× 796 1.8× 597 1.5× 309 1.1× 215 0.8× 114 2.1k
Deok‐Hwan Yang South Korea 22 455 0.9× 727 1.7× 688 1.8× 500 1.8× 397 1.6× 112 1.6k
Eefke Petersen Netherlands 21 924 1.9× 446 1.0× 270 0.7× 450 1.6× 132 0.5× 69 1.7k
Ho‐Jin Shin South Korea 22 944 1.9× 655 1.5× 691 1.8× 412 1.5× 399 1.6× 182 2.0k
Surender Juneja Australia 20 489 1.0× 375 0.9× 541 1.4× 168 0.6× 288 1.1× 85 1.3k
John L. Reagan United States 20 282 0.6× 580 1.3× 329 0.9× 453 1.6× 403 1.6× 107 1.5k
Daniele Laszlò Italy 20 597 1.2× 709 1.6× 649 1.7× 223 0.8× 94 0.4× 67 1.6k
Irena Sniecinski United States 22 1.1k 2.2× 510 1.2× 339 0.9× 375 1.3× 161 0.6× 49 1.8k
Taiga Nishihori United States 22 984 2.0× 751 1.7× 235 0.6× 344 1.2× 390 1.5× 169 1.7k

Countries citing papers authored by Deok‐Hwan Yang

Since Specialization
Citations

This map shows the geographic impact of Deok‐Hwan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deok‐Hwan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deok‐Hwan Yang more than expected).

Fields of papers citing papers by Deok‐Hwan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deok‐Hwan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deok‐Hwan Yang. The network helps show where Deok‐Hwan Yang may publish in the future.

Co-authorship network of co-authors of Deok‐Hwan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Deok‐Hwan Yang. A scholar is included among the top collaborators of Deok‐Hwan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deok‐Hwan Yang. Deok‐Hwan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ji Yun, Sung‐Soo Yoon, Deok‐Hwan Yang, et al.. (2025). Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera. Cancer Research and Treatment. 1 indexed citations
2.
Song, Ga‐Young, Seo-Yeon Ahn, Sung‐Hoon Jung, et al.. (2025). Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 281–288. 1 indexed citations
3.
Yhim, Ho‐Young, Yong Park, Jeong‐A Kim, et al.. (2024). Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study. The Korean Journal of Internal Medicine. 39(3). 501–512. 3 indexed citations
4.
Park, Changhee, Ho Sup Lee, Ka‐Won Kang, et al.. (2024). Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature Communications. 15(1). 2776–2776. 6 indexed citations
5.
Kim, Young Ju, Sungwoo Lee, Hee‐Ok Kim, et al.. (2024). Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation. Nature Communications. 15(1). 2919–2919. 2 indexed citations
6.
Kang, Sae‐Ryung, et al.. (2023). Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma. Healthcare. 11(8). 1171–1171. 3 indexed citations
7.
Lee, Sung‐Eun, Sung-Soo Yoon, Deok‐Hwan Yang, et al.. (2023). A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study. Blood. 142(Supplement 1). 4575–4575. 3 indexed citations
8.
Kim, Tae‐Hyung, Mihee Kim, Ga‐Young Song, et al.. (2023). Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia. Cancer Research and Treatment. 55(3). 1011–1022. 3 indexed citations
9.
Lee, Sung‐Eun, Sung-Soo Yoon, Deok‐Hwan Yang, et al.. (2023). P1042: COMPARISON OF THE RESPONSE TO ROPEGINTERFERON ALFA-2B IN HYDROXYUREA NAÏVE VERSUS RESISTANCE/INTOLERANCE POLYCYTHEMIA VERA: THE KOREAN SINGLE-ARM, OPEN-LABEL MULTICENTER STUDY. HemaSphere. 7(S3). e86929d8–e86929d8. 1 indexed citations
10.
Vo, Manh-Cuong, Seo-Yeon Ahn, Mihee Kim, et al.. (2022). Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Translational Oncology. 20. 101413–101413. 6 indexed citations
11.
Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations
12.
Song, Ga‐Young, Dok Hyun Yoon, Cheolwon Suh, et al.. (2020). Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma. Bone Marrow Transplantation. 56(5). 1205–1208. 10 indexed citations
13.
Kim, Tae‐Hyung, Joon Ho Moon, Jae-Sook Ahn, et al.. (2018). Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse. Blood. 132(15). 1604–1613. 77 indexed citations
14.
Lee, Yoo Jin, Dong Won Baek, Jae‐Sook Ahn, et al.. (2018). Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(12). e529–e535. 2 indexed citations
15.
16.
Pan, Hongying, et al.. (2015). Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients. Clinical Microbiology and Infection. 21(12). 1123.e1–1123.e9. 15 indexed citations
17.
Kim, Hee Nam, Nan Young Kim, Yu Li, et al.. (2009). Polymorphisms of drug‐metabolizing genes and risk of non‐Hodgkin lymphoma. American Journal of Hematology. 84(12). 821–825. 13 indexed citations
18.
Kim, Hee Nam, Il-Kwon Lee, Deok‐Hwan Yang, et al.. (2008). Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leukemia Research. 33(1). 82–87. 62 indexed citations
19.
Kim, Hee Nam, Yeo‐Kyeoung Kim, Je‐Jung Lee, et al.. (2007). Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. American Journal of Hematology. 82(9). 798–801. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jae‐Sook Ahn Breakdown of academic impact, for papers by Esa Jantunen Breakdown of academic impact, for papers by Deok‐Hwan Yang Breakdown of academic impact, for papers by Eefke Petersen Breakdown of academic impact, for papers by Ho‐Jin Shin Breakdown of academic impact, for papers by Surender Juneja Breakdown of academic impact, for papers by John L. Reagan Breakdown of academic impact, for papers by Daniele Laszlò Breakdown of academic impact, for papers by Irena Sniecinski Breakdown of academic impact, for papers by Taiga Nishihori
Rankless by CCL
2026